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Background: Previous reports have demonstrated similar survival for men and women on hemodialysis, despite
women’s increased survival in the general population.
Objectives: To examine the effect of age on mortality in women undergoing chronic hemodialysis.
Design: A retrospective cohort study using an administrative data registry, the Canadian Organ Replacement
Registry (CORR) from Jan. 2001 and Dec. 2009.
Setting: Canada.
Patients: 28,971 (Women 11,792 (40.7%), Men 17,179 (59.3%)) incident chronic hemodialysis patients who survived
greater than 90 days on dialysis.
Measurements: All-cause mortality.
Methods: Cox proportional hazards and competing risks models were employed to determine the independent
association between sex, age and likelihood of all-cause mortality with renal transplantation as the competing
outcome.
Results: During the study period, 6060 (51.4%) of women and 8650 (50.4%) of men initiating dialysis died. Younger
women experienced higher mortality (Age < 45: Women 22.5%, Men 18.2%, hazard ratio (HR) 1.31 (1.12-1.52))
whereas elderly women experience lower mortality (Age 75–85: Women 65%, Men 67.3%, HR 0.94 95% CI 0.88-0.99,
Age > 85: Women 66%, Men 70.2%, HR 0.83 95% CI 0.71-0.97) compared to men. This relationship persisted after
accounting for the competing risk of transplantation.
Limitations: The cause of death was unknown.
Conclusions: Women’s survival on chronic hemodialysis varies by age compared to men with a significantly higher
mortality in women younger than 45 years old and lower mortality in woman older than 75 years of age.Abrégé
Contexte: Des rapports précédents ont démontré une survie similaire pour les hommes et les femmes en
hémodialyse, malgré une meilleure survie pour les femmes dans la population générale.
Objectifs: Examiner l’incidence de l’âge sur la mortalité chez les femmes en hémodialyse chronique.
Type d’étude: Une étude de cohorte rétrospective basée sur un registre de données administratives, le Registre
canadien des insuffisances et des transplantations d’organes (RCITO), de janvier 2001 à décembre 2009.
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Échantillon: Canada
Participants: 28 971 (femmes 11 792 (40,7%), hommes 17 179 (59,3%)) nouveaux patients souffrant d’insuffisance
rénale et traités en hémodialyse, qui ont survécu plus de 90 jours.
Mesures: Mortalité toutes causes confondues.
Méthodes: On a eu recours au modèle des risques proportionnels de Cox et au modèle de probabilités
concurrentes pour déterminer l’association indépendante entre le genre, l’âge et les probabilités de mortalité toutes
causes confondues, et la transplantation rénale est considérée comme un résultat concurrent.
Résultats: Au cours de la période d’étude, 6 060 (51,4%) des femmes et 8 650 (50,4%) des hommes qui ont entamé
la dialyse sont décédés. La mortalité des jeunes femmes a été supérieure (âge < 45: femmes 22,5%, hommes 18,2%,
rapport des risques (hazard ratio, HR) 1,31 (1,12-1,52)), alors que la mortalité des femmes âgées a été inférieure
(âge 75-85: femmes 65%, hommes 67,3%, HR 0,9495% IC 0,88-0,99; âge >85: femmes 66%, hommes 70,2%, HR 0,83
95% IC 0,71-0,97) que celle des hommes. Ce rapport demeurait, après avoir pris en considération le risque
concurrent de la transplantation.
Limites de l’étude: La cause du décès est inconnue.
Conclusions: La survie des femmes en hémodialyse chronique, comparativement à celle des hommes, varie selon
l'âge. En effet, la mortalité des femmes de moins de 45 ans est significativement supérieure à celle des hommes du
même âge alors que celle des femmes âgées de plus de 75 ans est inférieure à celle des hommes de plus de 75 ans.What was known before
Women in the general population experience increased
longevity relative to men. Furthermore previous reports
have suggested higher mortality in younger woman on
hemodialysis. Whether this is true in a Canadian popu-
lation, after accounting for multiple confounders and
the competing risk of kidney transplantation, remains
unknown.
What this adds
We found that women’s survival on chronic hemodialysis
varies by age with higher mortality in women younger
than 45 years old and lower mortality in woman older
than 75 years of age compared to men and this was
persistent after accounting for the competing risk of
transplantation.
Background
Women comprise a significant and increasing proportion
of the worldwide dialysis population. Several studies
have identified significant differences in prevalence and
treatment of kidney disease between the sexes. Women
appear less likely than men to start dialysis for treatment
of kidney failure and less likely to receive a kidney trans-
plant [1-4]. Upon initiation of dialysis, women are more
likely to receive a lower dialysis dose, inferior treatment of
anemia and mineral metabolism complications, and have
a catheter as a vascular access [5-7]. Although, attempts to
mitigate sex-based differences in renal care have been
attempted; significant disparities still exist [5].
Despite clearly documented differences in the delivery
of dialysis care, the questions of whether these differencesadversely impact the outcome of women on dialysis
remains unclear. A small number of previous studies
suggest younger women on hemodialysis may have a
higher mortality relative to men [2,8,9]. Furthermore,
elderly women have been reported to have comparable
survival to elderly men on hemodialysis [2,8,9]. Whether
these findings are applicable to the Canadian dialysis
population remains unknown. In populations with dis-
parate rates of censoring and competing events, such
as differences in transplantation in end stage renal dis-
ease (ESRD), appropriate analyses must be employed
to account for these differences [10,11]. The use of
competing outcomes analyses has allowed considerable
insight into sex based disparities in transplantation
rates on hemodialysis demonstrating elderly women
are less likely to receive a renal transplant and young
African Americans on hemodialysis experience a higher
mortality [3,12]. Relatively healthy elderly women may re-
main on hemodialysis, as opposed to healthy elderly men
who may receive a transplant, creating a survival disparity.
Accounting for the competing event of transplantation
may alter the survival estimates of elderly women on
hemodialysis such that it mimics observations from the
general population, where women experience a survival
benefit and improved longevity compared to men.
In this regard we set out to examine sex-based differ-
ences on mortality among a chronic hemodialysis cohort
utilizing a competing risk analysis and whether age was
an effect modifier. We hypothesized that women would
experience higher survival after accounting for the
competing risk of transplantation and this would differ
by age.
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Sex and age-based patient characteristics
Women were the minority on hemodialysis therapies
across all age categories (Table 1). They comprised a
larger proportion of the hemodialysis population among
Aboriginal and East Asian’s. Older women (>45 years of
age) had a higher BMI and shorter pre-dialysis care than
men. Older men (>45 years of age) had more cardiac and
vascular disease, were more likely to be current cigarette
smokers and have a higher number of co-morbid illnesses.
Women were more likely to have interstitial disease as the
etiology of ESRD, and had a lower serum albumin and
hemoglobin. Younger women (<45 years or age) were more
likely to have pulmonary edema and malignancy at dialysis
initiation and less likely to be on an anti-hypertensive
medication. Lastly women were significantly less likely
to initiate hemodialysis with an arteriovenous fistula
(AVF) or arteriovenous graft (AVG) across all age groups
with absolute difference of 4.0 to 5.7%.Association of sex, age and mortality
In both unadjusted and adjusted models, mortality for
women was similar to men (HR 0.99 95% CI 0.96-1.03)
however it varied by age groups (age X sex interaction
p = 0.002). In individuals < 45 years of age, there were
317 (22.5%) and 391 (18.2%) deaths in women and men
respectively, an absolute difference of 4.3% (crude mor-
tality rate: women 4.53 and men 3.49 per 100 patient
years, Table 2). After adjustment, this difference in mortal-
ity persisted as women under the age of 45 had a higher
mortality compared to men (HR 1.31 95%CI 1.12-1.52)
(see Figure 1). Conversely, women over 75 years of age
experienced a modest survival benefit relative to men (age
75–85: HR 0.93 95% CI 0.87-0.99, age > 85: HR 0.82 95%
CI 0.70-0.96).Association of sex, age and mortality accounting for
transplantation
In our analyses accounting for transplantation we used
fewer age categories (<40, 40–50, 51–60, >60) to reflect
that few individuals greater than 60 years of age receive
a renal transplant. Utilizing a Fine and Gray model ac-
counting for the competing risk (hazard ratio competing
HRc) of transplantation, the hazard ratio for mortality in
women compared to men was similar as traditional cox
models (HR) (age < 40: HRc 1.32 (1.14-1.54) HR 1.35
(1.10-1.66), age 40–50 HRc 1.01 (0.90-1.13) HR 1.04
(0.90-1.20), age 51–60 HRc 1.03 (0.95-1.11) HR 1.01
(0.93-1.11), age > 60 HRc 1.02 (0.96-1.08) HR 1.00 (0.96-
1.04). Women were less likely to receive a renal trans-
plant compared to men, especially in those > 50 years of
age (age 51–60: HRc 0.65 95% CI 0.55-0.77, > 60: HRc
0.56 95% CI 0.41-0.76).Discussion
In this large national cohort of patients on chronic
hemodialysis, substantial mortality differences were evi-
dent among the sexes based on age. Although overall
mortality for men and women after comprehensive ad-
justment was similar, age was a significant effect modi-
fier as women under the age of 45 years of age had a
substantially higher mortality risk compared to men of a
similar age. In contrast, women over the age of 75 years
of age experienced a modestly lower mortality, an obser-
vation consistent with data in the general population.
These differences persisted after accounting for the
competing risk of transplantation and after comprehensive
adjustment for confounders.
The finding that mortality is increased in women < 45
years of age on hemodialysis relative to men is congruent
with finding from previous studies from Europe and
the United States [2,8,9]. Crude mortality rates for
hemodialysis patients from the United States Renal Data
System (USRDS) show higher mortality in women under
the age of 60 years of age compared to men with the lar-
gest disparity among those aged 20–29 years of age
(Crude mortality rate male 4.93 women 6.29 per 100 pa-
tient years; relative rate 1.27). Similarly, data from the
Renal Epidemiology and Information Network (REIN)
registry in France reported an increase in the standardized
mortality ratio in women relative to men, predominantly
due to mortality in the first four years on dialysis. Our
findings are consistent with these previous reports and
demonstrate the mortality difference persists after ad-
justment for numerous confounders and after account-
ing for the competing outcome of transplantation.
We observed women greater than 75 years of age had
a higher mortality compared to men. We found absolute
mortality reductions of 2.3% and 4.2% in women 75 to
85 years of age and over 85 years of age relative to simi-
lar aged men. This observation mimics those seen in the
Canadian general population where women experience,
on average, an additional 4 years of longevity relative to
men [13]. However it is unclear if the survival benefit is
simply an extension of those observed in the general
population or due to the possibility of a selection bias.
There have been numerous reports that elderly women
do not receive equal access to cardiovascular procedures,
surgical interventions and kidney transplantation [14-16].
Elderly women may not choose or be offered chronic
hemodialysis to the same extent as men thus altering
the population on chronic hemodialysis. Further inves-
tigations regarding sex-based differences in acceptance
and offer of dialysis treatment are required.
It is well known that kidney transplantation as a treat-
ment for kidney failure is less frequent among women
than men. In our cohort, we also found that the likelihood
of receiving a kidney transplant was lower across all age
Table 1 Characteristics of the study cohort stratified by sex and age categories
Characteristic Age < 45 Age 45-75 Age > 75
Women Men P value Women Men P value Women Men P value
N % 39.5(1406) 60.5(2152) 40.0(7044) 60.0(10585) 42.9(3342) 57.1(4442)
Age (±SD) 35.5 ± 7.4 35.9 ± 7.2 0.1 63.4 ± 8.2 62.9 ± 8.3 <0.0001 81.0 ± 4.0 80.9 ± 4.0 0.5
Race <0.0001 <0.0001 0.02
Caucasian 57.6(810) 65.1(1400) 70(4856) 74(7490) 77.8(2599) 80.6(3579)
Aboriginal 15.9(223) 10.3(222) 7.3(644) 4.8(635) 1.6(53) 1.1(51)
East Asian 6.8(95) 5.3(115) 5.1(359) 6.6(541) 7.8(260) 6.2(275)
Black 6.1(86) 5.4(116) 3.4(724) 2.8(1234) 9.2(306) 8.9(397)
South Asian 9.2(129) 9.3(201) 11.1(255) 9.1(345) 1.7(57) 1.3(58)
Other 4.5(63) 4.6(98) 3.1(206) 2.7(340) 2.0(67) 1.8(82)
BMI (±SD) 27.2 ± 8.6 26.9 ± 6.5 0.2 28.9 ± 8.1 27.9 ± 6.4 <0.0001 25.8 ± 6.1 25.4 ± 5.3 <0.0001
Distance to nearest dialysis facility in km (IQR) 11.4(5.0-62.2) 11.7(4.8-62.4) 0.7 12.0(4.9-59.5) 12.0(5.0-55.5) 0.9 8.6(4.0-28.8) 9.4(4.4-34.8) 0.06
Any pre-dialysis care % (N) 53.2(748) 50.9(1096) 0.2 58.5(4122) 58.7(6212) 0.8 57.2(1911) 59.2(2630) 0.07
Median number of days with pre-dialysis care (IQR) 562(220–1532) 574(211–1339) 0.9 133 (0–747) 140(0–812) 0.03 587 (217–1218) 666(246–1362) 0.003
Geographic region % (N) 0.08 0.06 0.2
Atlantic 9.2(129) 9.4(202) 11.6(815) 10.8(1137) 10.3(342) 10.4(461)
Central 19.3(685) 31.6(1122) 51.6(3626) 53.2(5618) 59.2(1969) 57.7(2558)
Prairie 12(425) 15.9(566) 24.3(1705) 23.2(2447) 17.6(586) 19.5(863)
Pacific 11.8(166) 12.0(258) 12.5(882) 12.9(1367) 13(431) 12.5(555)
Co-morbidities: % (N)
CAD 5.1(72) 5.6(120) 0.6 22.3(1572) 23.7(2508) 0.04 26.4(881) 29.1(1292) 0.008
AMI 3.4(48) 3.8(82) 0.6 19.4(1370) 25.2(2666) <0.0001 22.9(765) 30.3(1344) <0.0001
Pulmonary edema 14.4(202) 11.6(249) 0.02 29.5(2080) 26.8(2837) <0.0001 32(1070) 30.5(1357) 0.2
DM 35.2(495) 36(774) 0.7 56.6(3984) 55.1(5932) 0.06 38.3(1279) 36.1(1602) 0.05
Stroke 3.8(54) 3.3(70) 0.4 14.0(988) 14.6(1541) 0.3 16.7(557) 19.5(865) 0.002
PVD 6.7(94) 6.7(144) 0.9 17.9(1263) 22.4(2370) <0.0001 17.7(590) 23.8(1055) <0.0001
Malignancy 3.4(48) 1.8(38) 0.002 10.7(757) 11.5(1217) 0.2 15(500) 21.5(957) <0.0001
Lung disease 3.4(48) 2.3(49) 0.05 12.7(894) 11.5(1215) 0.02 12.1(405) 15.4(683) <0.0001
HTN 71.3(1003) 77.6(1670) <0.0001 83.3(5870) 83.2(8803) 0.8 84.4(2819) 82(3642) 0.006
Serious illness 9.7(136) 8.5(183) 0.3 11.3(794) 11.3(1198) 0.9 9.4(314) 9.8(437) 0.5
Current smoker 18.5(260) 22.6(487) 0.003 13.4(943) 15.8(1675) <0.0001 5.3(176) 7(313) 0.001
CABG 2.6(36) 1.9(41) 0.2 10.6(748) 16.9(1794) <0.0001 12.3(412) 20.5(909) <0.0001




















Table 1 Characteristics of the study cohort stratified by sex and age categories (Continued)
Cause of ESRD % (N) 0.02 <0.0001 <0.0001
Vascular 6.9(97) 9.3(200) 17.2(1214) 18.3(1938) 39.3(1312) 39.3(1744)
DM 31.1(437) 31.4(676) 45.8(3227) 44.3(4694) 26.8(897) 25(1111)
GN 33.6(472) 31.9(687) 12.2(859) 13.7(1449) 8.7(291) 8.8(389)
Obstruction 4.6(64) 3.9(83) 2.2(153) 3.0(314) 2.4(81) 4.0(179)
Interstitial 1.6(22) 0.6(13) 1.3(94) 0.7(74) 1.6(53) 0.9(38)
PCKD 5.8(82) 5.3(114) 4.6(323) 4.2(445) 1.8(61) 1.6(73)
Other 7.8(109) 8.2(177) 8.6(607) 7.9(841) 6.5(217) 6.3(279)
Unknown 8.7(123) 9.4(202) 8.0(567) 7.8(830) 12.9(430) 14.2(629)
Serum Albumin g/L (±SD) 30.1 ± 10.5 31.5 ± 10.3 <0.0001 31.1 ± 9.5 31.8 ± 9.3 <0.0001 32.2 ± 8.8 32.2 ± 7.1 0.8
Hemoglobin g/L (±SD) 93.9 ± 26.7 97.1 ± 23.9 <0.0001 99.5 ± 32.2 100.3 ± 21.1 0.03 102.0 ± 25.3 102.7 ± 23.9 0.2
AVF/AVG % (N) 11.6(163) 17.3(372) <0.0001 16.6(1168) 20.6(2181) <0.0001 14.5(483) 18.9(838) <0.0001
N number, % percentage, SD standard deviation, BMI body mass index, IQR interquartile range, km kilometer, Atlantic include Newfoundland, New Brunswick, Nova Scotia, prince Edward Island, Central Ontario, Prairie
Manitoba, Saskatchewan, Alberta, Pacific British Columbia. CAD coronary artery disease, AMI acute myocardial infarction, DM diabetes mellitus, HTN hypertension, CABG coronary artery bypass graft, ESRD end stage




















Table 2 Crude numbers and proportions of mortality on hemodialysis in women according to age categories with men
as the referent
Age group (in years) Women Male
Number of deaths Proportion of total Number of deaths Proportion of total
<45 317 22.5 391 18.2
45-55 499 35.0 833 35.2
55-65 1120 48.3 1667 46.6
65-75 1947 59.0 2753 59.3
75-85 1880 65.0 2568 67.3
>85 297 66.0 438 70.2
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explain the age-related mortality differences among the
sexes since, after accounting for the competing risk of
transplantation, there was little change in the observed
mortality risk. Thus young women on dialysis are disad-
vantaged by both a higher risk of mortality and a reduced
likelihood of receiving a renal transplant.
We did find several risk factors that may contribute to
the higher mortality observed in younger woman on
dialysis. Woman less than 45 years of age had an almost
two-fold increase in malignancy, were more likely to
have glomerulonephritis, obstruction or interstitial dis-
ease as their cause of renal failure, have a lower serum
albumin and hemoglobin and were 5.7% less likely to
initiate dialysis with a fistula. Of these only vascular
access represents a potentially modifiable risk factor.
Multiple studies have reported lower rates of AVF among
women however it remains unclear if this represents
actual differences in patient agreement for AVF, referral
rates, AVF creation and/or maturation among the sexesFigure 1 Adjusted survival in women on hemodialysis stratified
by age with men as the referent. *Model adjusted for
demographics, co-morbidities, body mass index (BMI), distance from
centre, pre-dialysis care, cause of end stage renal disease, geographic
region, serum hemoglobin and albumin.[17-19]. Technical difficulties may include smaller vessel
diameter or early thrombosis. Miller et al. reported
post-AVF creation women are less likely to achieve fis-
tula patency and are more likely to have early throm-
bosis and undergo more salvage procedures compared
to men. A similar increase in complications and the
need for more revascularization procedures has been
reported in AVG in women compared to men [20]. It is
possible that there may be important cosmetic consid-
erations as young women may be less agreeable to AVF
surgery. Attitudes towards vascular access suggest body
image is an important consideration however whether it is
sex-specific remains unclear [21].
The main strengths of our study are the use of a large
national cohort with over 10 years of incident patient
follow up. CORR captures data on almost all patients
who initiate hemodialysis in Canada. We were able to
perform more comprehensive covariate adjustment than
previous studies including co-morbidities, modality,
vascular access, laboratory parameters, geography, pre-
dialysis care and distance to dialysis facility. We also
accounted for the competing outcome of transplantation
in our survival analysis.
Conversely, our study had limitations. As in any obser-
vational study, residual confounding cannot be ruled out
as an alternative explanation for our findings. We lacked
detailed information regarding the cause of death. We
did not account for modality transitions namely initiation
of dialysis on peritoneal and transitions to hemodialysis.
Our vascular access measurements were taken at initi-
ation of dialysis, did not reflect changes that occur over
time and may not reflect access function. The distance
from dialysis centre was direct linear distance and may
not accurately reflect driving distances or travelling time.
We lacked information on the source (living, deceased) of
organ procurement.
Conclusion
In conclusion we found that age is an important effect
modifier in survival of women on hemodialysis. Young
women experienced a considerably higher mortality relative
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advantage. This was consistent after accounting for the
competing risks of renal transplantation. Further sex-
specific investigations are required into the mechanisms
and possible prevention of these mortality disparities.
Methods
Study design and cohort development
This study was approved by the Research Board and the
Hospital Ethics Board at St. Boniface Hospital in Winnipeg,
Manitoba. We used the Canadian Organ Replacement
Registry (CORR) as the source cohort for this analysis.
CORR is a validated ESRD registry that captures data on
all dialysis patients in Canada including demographics,
death, dialysis modality, comorbidities and transplant-
ation who supply written consent [22,23]. We included
all adult patients starting hemodialysis between January
1, 2001 and December 2009 who survived greater than
90 days. Patients with missing co-morbidity information
were excluded (N =1,408). The final analytic cohort in-
cluded 28,971 (Women 11,792 (40.7%), Men 17,179
(59.3%)). All data was de-identified, retrospective from
the CORR and thus individual participant consent was
not required.
Definitions
Co-morbid illnesses included a history of coronary artery
disease, acute myocardial infarction, diabetes mellitus,
pulmonary edema, peripheral vascular disease, malignancy,
hypertension medication usage, current cigarette smoker,
lung disease, any serious illness and stroke. Serious illness
was defined as any illness that could shorten life expectancy
to less than 5 years. Causes of ESRD included vascular
disease, diabetes mellitus, glomerulonephritis, interstitial
disease, polycystic kidney disease, obstruction, other and
unknown. Provinces and territories were categorized as
geographic regions as follows: Atlantic (New Brunswick,
Nova Scotia, Prince Edward Island, Newfoundland),
Central (Ontario), Prairies (Alberta, Saskatchewan, Manitoba,
Nunavut, Northwest Territories), Pacific (British Columbia,
Yukon). Any pre-dialysis care was defined as contact with
a Nephrologist for 30 or more days prior to hemodialysis
initiation. Distance to centre was calculated as the direct
linear distance in kilometres between a patients postal
code from their primary residence at dialysis initiation to
the nearest dialysis provider. Comorbidities and laboratory
data were ascertained at the onset of ESRD. The outcome
of interest was all-cause mortality and follow-up for out-
comes was until December 31st, 2009.
Statistical analyses
Continuous variables of interest were summarized as mean
or medians with standard deviation or inter-quartile range
as appropriate. Differences in baseline characteristics weredetermined by student’s t-test for continuous variables
and chi-square or the Mann–Whitney test for dichot-
omous variables.
To assess the relationship between the sexes and
mortality, we examined both traditional cause-specific cox
proportional hazards model and the modified risks regres-
sion model of Fine and Gray to account for the competing
risk of transplantation [24]. Models were adjusted for
demographics, co-morbidities, body mass index (BMI),
distance from centre, pre-dialysis care, cause of ESRD,
geographic region, serum hemoglobin and albumin. The
competing risk accounted for in the Fine and Gray models
was renal transplantation.
To assess whether age was an effect modifier for mor-
tality among the sexes, an age X sex interaction term
was added separately to the traditional cox and compet-
ing risks models. In separate models, age was entered
both as a continuous variable and categorical variable
(age < 45, 45–55, 55–65, 65–75, 75–85, 85+ years). Cat-
egories were created based on the number of death events
and individual models were created per age stratum with
men as the referent. As there are few kidney transplants
with increasing age, age categories were collapsed in the
competing risk models.
Multiple imputation was employed for missing values
with a random draw from the predictive distribution
from an imputation model repeated ten times [25]. The
proportion and covariates with missing data that was
imputed included BMI (8.2%), distance from centre
(2.0%), cause of ESRD (2.9%), geographic region (0.2%),
serum hemoglobin (15.4%) and albumin (21.5%). An
iterative Markov chain Monte Carlo (MCMC) method
was used and pooled estimates of 10 rounds of imput-
ation reported. Imputed and non-imputed models were
compared and as there were no substantive changes in
point estimates, the pooled imputed results of 10 rounds
of imputation were reported. Analyses were performed
using PASW Version 18 and the Fine and Gray analyses
were performed using R. All hypothesis tests were
two sided with statistical significance to find as having a
P value of <0.05.
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